While we acknowledge that these assertions are drawn from our observations and represent assumptions, future investigations, supported by rigorous clinical studies, will be imperative to validate and build upon these preliminary findings, deepening our understanding of the intricate interplay between AR-V7, AR-FL, and drug efficacy in the context of glioblastoma. Here, AR is linked to glioblastoma.